APA (7th ed.) Citation

Wanas, H., Rabie, M. A., Aboulhoda, B. E., Ramadan, N. M., Abdelwahab, S., Abdallah, S. S. K., . . . Khalifa, A. K. (2024). The potential therapeutic role of Lisinopril in augmenting the striatal neuroplasticity via the striatal ACE2/Ang1-7/MAS receptor axis in 3-nitropropionic acid-induced Huntington's disease in rats: Shifting paradigms in Huntington's disease treatment. Future Journal of Pharmaceutical Sciences, 10(1), 1. https://doi.org/10.1186/s43094-024-00724-z

Chicago Style (17th ed.) Citation

Wanas, Hanaa, et al. "The Potential Therapeutic Role of Lisinopril in Augmenting the Striatal Neuroplasticity via the Striatal ACE2/Ang1-7/MAS Receptor Axis in 3-nitropropionic Acid-induced Huntington's Disease in Rats: Shifting Paradigms in Huntington's Disease Treatment." Future Journal of Pharmaceutical Sciences 10, no. 1 (2024): 1. https://doi.org/10.1186/s43094-024-00724-z.

MLA (9th ed.) Citation

Wanas, Hanaa, et al. "The Potential Therapeutic Role of Lisinopril in Augmenting the Striatal Neuroplasticity via the Striatal ACE2/Ang1-7/MAS Receptor Axis in 3-nitropropionic Acid-induced Huntington's Disease in Rats: Shifting Paradigms in Huntington's Disease Treatment." Future Journal of Pharmaceutical Sciences, vol. 10, no. 1, 2024, p. 1, https://doi.org/10.1186/s43094-024-00724-z.